The onset of alcuronium and tubocurarine: alone and in combination

The rates of onset of neuromuscular blockade have been measured following 0.25 mg.kg‐1 alcuronium (ED95), 0.51 mg.kg‐1 tubocurarine (ED95), a combination of 50% of the ED95 of each and a combination of 33% of the ED95 of each. Train‐of‐four stimulation of the ulnar nerve was used with recording of the amplitude of the evoked compound electromyogram from the thenar prominence. The rate of increase in blockade in patients receiving the 50% combination was significantly greater than for either agent given alone, or than for the 33% combination. The mean time to 75% block of the first contraction of the train (T1) with the 50% mixture was 90 s, significantly faster than alcuronium alone (132 s), tubocurarine alone (174 s) or the 33% mixture (127 s). These latter three groups did not differ significantly. In conclusion, the rate of onset of the 50% combination resulted in a more rapid onset of neuromuscular blockade, whereas the rate of onset of the 33% combination was no different to that of either drug alone. This small degree of acceleration with agents which are known to be markedly synergistic makes it unlikely that this technique will prove to be of clinical importance.

[1]  D. R. Cook,et al.  Neuromuscular and Cardiovascular Effects of High‐Dose Vecuronium , 1990, Anesthesia and analgesia.

[2]  R. M. Jones The priming principle: how does it work and should we be using it? , 1989, British journal of anaesthesia.

[3]  B. Pollard Priming with alcuronium and tubocurarine accelerates the onset of neuromuscular block. , 1989, British journal of anaesthesia.

[4]  R. M. Jones,et al.  Fade characteristics and onset times following administration of pancuronium, tubocurarine and a mixture of both agents. , 1985, British journal of anaesthesia.

[5]  B. Kay,et al.  Neuromuscular block: atracurium and vecuronium compared and combined. , 1985, European journal of anaesthesiology.

[6]  R. M. Jones,et al.  Interactions between tubocurarine, pancuronium and alcuronium demonstrated in the rat phrenic nerve-hemidiaphragm preparation. , 1983, British journal of anaesthesia.

[7]  H. H. Ali,et al.  Combination of Pancuronium and Metocurine: Neuromuscular and Hemodynamic Advantages over Pancuronium Alone , 1981, Anesthesia and analgesia.

[8]  H. H. Ali,et al.  Potentiation of Neuromuscular Blockade in Man Produced by Combinations of Pancuronium and Metocurine or Pancuronium and d‐Tubocurarine , 1980, Anesthesia and analgesia.

[9]  A. T. Birmingham,et al.  Comparative Potency and Speed of Onset of Fazadinium and d‐Tubocurarine , 1979, Acta anaesthesiologica Scandinavica.

[10]  C. Blackburn,et al.  Comparison of speed of onset of fazadinium, pancuronium, tubocurarine and suxamethonium. , 1978, British journal of anaesthesia.

[11]  Murray Aitkin,et al.  The Analysis of Unbalanced Cross-classifications , 1978 .

[12]  R. Kitz,et al.  The Quest for a Short‐Acting Nondepolarizing Neuromuscular Blocking Agent , 1974, Acta anaesthesiologica Scandinavica. Supplementum.

[13]  Bennett Ej,et al.  Pancuronium bromide: a double-blind comparison with d-tubocurarine for intubation in adults. , 1973 .

[14]  L. Theodorsen,et al.  Sensitivity to tubocurarine and alcuronium with special reference to plasma protein pattern. , 1971, Anaesthesia.

[15]  D. Waud The rate of action of competitive neuromuscular blocking agents. , 1967, The Journal of pharmacology and experimental therapeutics.